top of page
Researcher

EPI-Net

Start Date:

January 2015

End Date:

ongoing

Duration:

72 months

ID-CARE Role:
Website:

Partner, Work Package (WP) Leader

Description

Title: Epidemiology Network


Background: EPI-Net is a network of epidemiological surveillance experts and stakeholders in Europe, mapping current systems; to define methodological challenges, and develop research strategy for epidemiological studies; to pursue consensus for best-practices; and support research and development for new, effective antibiotics.


Primary Objective: to create an up-to-date surveillance platform integrating data from humans and animals, and providing information on prevalence and incidence of antimicrobial resistance (AMR) and healthcare associated infections (HAI), AMR outbreaks and emerging resistances to newly approved antibiotics, from epidemiological studies and surveillance systems in Europe.


Secondary Objective:

  • Implementation of frameworks for semi-automation of procedures for surveillance of HAIs

  • Building networks of healthcare centres sharing epidemiological data to receive statistical model-supported individualised feedback on interventions to reduce setting-specific AMR rates

  • Develop a consensus program to contribute to the homogenization of the approach on current and future epidemiologic surveillance strategies in Europe

  • Development of standardised decision-support models, capable of defining the thresholds in resistance data for various infectious disease syndromes and changing empirical antibiotic treatment protocols accordingly

  • Analysis of burden and outcomes of infections due to multidrug resistant organisms to inform Public Health Action

Partners

University of Verona - ITALY (Coordinator) 

AiCuris Anti-infective Cures GmbH - GERMANY

Astra-Zeneca - ITALY

Basilea Pharmaceutica International - SWITZERLAND

Centre Hospitalier de LIMOGES - FRANCE

Eberhard Karls Universität Tuebingen - GERMANY

Fondazione PENTA - ITALY

GlaxoSmithKline Research and Development Ltd - UK

Institut Català de la Salut - Hospital Universitari de Bellvitge - SPAIN

Sanofi U.S. - US

Servicio Andaluz de Salud - SPAIN

Stichting Katholieke Universiteit - NETHERLANDS

Radboud University Nijmegen Medical Centre - NETHERLANDS

University Medical Center Utrecht (UMCU) - NETHERLANDS

University of Geneve - SWITZERLAND

Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications

The Lancet Regional Health–Europe

22/12/22

EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach

Clinical Microbiology and Infection

18/7/21

PRAISE: Providing a roadmap for automated infection surveillance in Europe

Journal of Antimicrobial Chemotherapy

5/12/20

White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks

Clinical Microbiology and Infection

4/12/19

Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries

Antimicrobial Resistance & Infection Control

29/5/18

Social media posts and online search behaviour as early-warning system for MRSA outbreaks

Clinical Microbiology and Infection

24/7/17

The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information.

Clinical Microbiology and Infection

1/7/22

What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review

Journal of Antimicrobial Chemotherapy

5/12/20

White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks

Journal of Antimicrobial Chemotherapy

5/12/20

White Paper: bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks

Journal of Antimicrobial Chemotherapy

5/9/19

Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list

The Lancet Infectious Diseases

28/2/18

Surveillance for control of antimicrobial resistance

BMJ Open

27/3/17

Surveillance systems from Public Health institutions and scientific societies for antimicrobial resistance and healthcare associated infections in Europe (SUSPIRE): protocol for a systematic review

Journal of Fungi

27/2/22

Surveillance of antifungal resistance in Candidemia fails to inform antifungal stewardship in European countries

Journal of Antimicrobial Chemotherapy

5/12/20

White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks

Infection Control & Hospital Epidemiology

29/12/19

A framework to develop semiautomated surveillance of surgical site infections: an international multicenter study

Journal of Fungi

3/6/19

Does online search behavior coincide with Candida auris cases? An exploratory study

Clinical Microbiology and Infection

1/9/17

A review of antimicrobial resistance surveillance programmes in livestock and meat thereof in Europe with a focus on antimicrobial resistance patterns in humans.

BMJ Open

5/1/17

EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.

ID-CARE Participants

Evelina Tacconelli

Director

Elisa Carli

Research Assistant

Federica Manco

Research Assistant

Cristina Magnabosco

Research Assistant

Jacopo Garlasco

Research Assistant

Fabiana Arieti

Clinical Research Assistant & Project Manager

bottom of page